APA aipamena

Ghiaseddin, A., Reardon, D., Massey, W., Mannerino, A., Lipp, E. S., Herndon, J. E., . . . Peters, K. B. (2017). Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma. Oncologist.

Chicago Style aipamena

Ghiaseddin, Ashley, et al. "Phase II Study of Bevacizumab and Vorinostat for Patients With Recurrent World Health Organization Grade 4 Malignant Glioma." Oncologist 2017.

MLA aipamena

Ghiaseddin, Ashley, et al. "Phase II Study of Bevacizumab and Vorinostat for Patients With Recurrent World Health Organization Grade 4 Malignant Glioma." Oncologist 2017.